Ameriprise Financial Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 219,256 shares of ARWR stock, worth $4.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

219,256

Previous 738,200 70.3%

Holding current value

$4.3 Million

Previous $19.2 Million 77.88%

% of portfolio

0.0%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.36 - $29.54 $10 Million - $15.3 Million	-518,944 Reduced 70.3%	219,256 $4.24 Million
Q2 2024 Aug 14, 2024	SELL	$21.87 - $28.24 $5.67 Million - $7.32 Million	-259,097 Reduced 25.98%	738,200 $19.2 Million
Q1 2024 May 15, 2024	BUY	$27.21 - $39.48 $1.87 Million - $2.71 Million	68,697 Added 7.4%	997,297 $28.5 Million
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $4.98 Million - $7.29 Million	234,984 Added 33.88%	928,600 $28.4 Million
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $6.35 Million - $8.74 Million	242,277 Added 53.68%	693,616 $18.6 Million
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $375,865 - $618,175	-14,939 Reduced 3.2%	451,339 $16.1 Million
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $931,973 - $1.52 Million	-39,357 Reduced 7.78%	466,278 $11.8 Million
Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $703,864 - $1.02 Million	-25,138 Reduced 4.74%	505,635 $20.5 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $221,039 - $360,392	-7,460 Reduced 1.39%	530,773 $17.5 Million
Q2 2022 Aug 15, 2022	BUY	$27.79 - $50.61 $58,414 - $106,382	2,102 Added 0.39%	538,233 $19 Million
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $318,584 - $562,628	-8,041 Reduced 1.48%	536,131 $24.7 Million
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $2.79 Million - $3.96 Million	47,975 Added 9.67%	544,172 $36.1 Million
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $114,775 - $167,031	-1,966 Reduced 0.39%	496,197 $31 Million
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $301,862 - $438,684	4,857 Added 0.98%	498,163 $41.3 Million
Q1 2021 May 17, 2021	BUY	$61.35 - $90.47 $1.08 Million - $1.59 Million	17,624 Added 3.7%	493,306 $32.7 Million
Q4 2020 Feb 12, 2021	SELL	$43.82 - $85.37 $2.56 Million - $4.98 Million	-58,377 Reduced 10.93%	475,682 $36.5 Million
Q3 2020 Nov 16, 2020	BUY	$33.21 - $51.27 $3.23 Million - $4.99 Million	97,361 Added 22.29%	534,059 $23 Million
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $2.39 Million - $3.96 Million	91,533 Added 26.52%	436,698 $18.9 Million
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $334,490 - $1.03 Million	-16,269 Reduced 4.5%	345,165 $9.93 Million
Q4 2019 Feb 14, 2020	SELL	$28.14 - $73.01 $5.01 Million - $13 Million	-177,931 Reduced 32.99%	361,434 $22.9 Million
Q3 2019 Nov 14, 2019	BUY	$26.26 - $34.86 $436,204 - $579,059	16,611 Added 3.18%	539,365 $15.2 Million
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $9.11 Million - $15.1 Million	522,754 New	522,754 $13.9 Million
Q1 2019 May 15, 2019	SELL	$12.05 - $20.18 $1,144 - $1,917	-95 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$10.74 - $19.7 $805,167 - $1.48 Million	-74,969 Reduced 99.87%	95 $1,000
Q3 2018 Nov 14, 2018	BUY	$14.0 - $20.3 $889,896 - $1.29 Million	63,564 Added 552.73%	75,064 $1.44 Million
Q2 2018 Aug 14, 2018	BUY	$6.37 - $14.02 $73,255 - $161,230	11,500 New	11,500 $156,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.08B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Arrowhead Pharmaceuticals, Inc. Transaction History